Michael H. Davidson - Dec 29, 2023 Form 3/A Insider Report for NewAmsterdam Pharma Co N.V. (NAMS)

Role
Chief Executive Officer, Director
Signature
/s/ Louise Kooij by Power of Attorney for Michael H. Davidson
Stock symbol
NAMS
Transactions as of
Dec 29, 2023
Transactions value $
$0
Form type
3/A
Date filed
1/25/2024, 05:00 PM
Date Of Original Report
Dec 29, 2023
Previous filing
Jun 10, 2022
Next filing
Jan 3, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding NAMS Warrant (right to buy) Dec 29, 2023 Ordinary Shares 100K $11.50 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This amendment is being filed to include warrants to purchase ordinary shares inadvertently omitted from the Form 3 filed by the Reporting Person on December 29, 2023.